279 related articles for article (PubMed ID: 10188886)
1. Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs.
Will BP; Le Petit C; Berthelot JM; Tomiak EM; Verma S; Evans WK
Br J Cancer; 1999 Mar; 79(9-10):1428-36. PubMed ID: 10188886
[TBL] [Abstract][Full Text] [Related]
2. Estimates of the lifetime costs of breast cancer treatment in Canada.
Will BP; Berthelot JM; Le Petit C; Tomiak EM; Verma S; Evans WK
Eur J Cancer; 2000 Apr; 36(6):724-35. PubMed ID: 10762744
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and therapeutic approaches to lung cancer in Canada and their costs.
Evans WK; Will BP; Berthelot JM; Wolfson MC
Br J Cancer; 1995 Nov; 72(5):1270-7. PubMed ID: 7577481
[TBL] [Abstract][Full Text] [Related]
4. Lifetime costs of colon and rectal cancer management in Canada.
Maroun J; Ng E; Berthelot JM; Le Petit C; Dahrouge S; Flanagan WM; Walker H; Evans WK
Chronic Dis Can; 2003; 24(4):91-101. PubMed ID: 14733758
[TBL] [Abstract][Full Text] [Related]
5. [Standard treatment cost of female breast cancer at different TNM stages].
Li H; Huang Y; Huang R; Li JY
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):946-50. PubMed ID: 24506967
[TBL] [Abstract][Full Text] [Related]
6. Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.
Evans WK; Will BP; Berthelot JM; Wolfson MC
Can J Oncol; 1995 Dec; 5(4):408-19. PubMed ID: 8770457
[TBL] [Abstract][Full Text] [Related]
7. Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer.
Barlow WE; Taplin SH; Yoshida CK; Buist DS; Seger D; Brown M
J Natl Cancer Inst; 2001 Mar; 93(6):447-55. PubMed ID: 11259470
[TBL] [Abstract][Full Text] [Related]
8. Healthcare Utilization and Costs During the Initial Phase of Care Among Elderly Women With Breast Cancer.
Vyas A; Madhavan SS; Sambamoorthi U; Pan XL; Regier M; Hazard H; Kalidindi S
J Natl Compr Canc Netw; 2017 Nov; 15(11):1401-1409. PubMed ID: 29118232
[No Abstract] [Full Text] [Related]
9. A model for estimating the costs and burdens of breast cancer diagnosis and treatment in Canada.
Will BP; Berthelot JM; Houle C; Verma S; Tomiak E; Evans WK
Health Rep; 1993; 5(4):399-408. PubMed ID: 8011960
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer: better care for less cost. Is it possible?
Evans WK; Will BP; Berthelot JM; Logan DM; Mirsky DJ; Kelly N
Int J Technol Assess Health Care; 2000; 16(4):1168-78. PubMed ID: 11155836
[TBL] [Abstract][Full Text] [Related]
11. Incidence-based cost-of-illness model for metastatic breast cancer in the United States.
Sorensen SV; Goh JW; Pan F; Chen C; Yardley D; Martín M; Knopf K; Benedict A; Giorgetti C; Iyer S
Int J Technol Assess Health Care; 2012 Jan; 28(1):12-21. PubMed ID: 22617734
[TBL] [Abstract][Full Text] [Related]
12. The economics of lung cancer management in Canada.
Evans WK; Will BP; Berthelot JM; Wolfson MC
Lung Cancer; 1996 Feb; 14(1):19-29. PubMed ID: 8696718
[TBL] [Abstract][Full Text] [Related]
13. Expected 10-year treatment cost of breast cancer detected within and outside a public screening program in Norway.
Moger TA; Bjørnelv GM; Aas E
Eur J Health Econ; 2016 Jul; 17(6):745-54. PubMed ID: 26239280
[TBL] [Abstract][Full Text] [Related]
14. Metastatic breast cancer: we do need primary cost data.
Bonastre J; Jan P; Barthe Y; Koscielny S
Breast; 2012 Jun; 21(3):384-8. PubMed ID: 22520336
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant Chemotherapy Use and Health Care Costs After Introduction of Genomic Testing in Breast Cancer.
Epstein AJ; Wong YN; Mitra N; Vachani A; Hin S; Yang L; Smith-McLallen A; Armstrong K; Groeneveld PW
J Clin Oncol; 2015 Dec; 33(36):4259-67. PubMed ID: 26598749
[TBL] [Abstract][Full Text] [Related]
16. Costs of treatment for elderly women with early-stage breast cancer in fee-for-service settings.
Warren JL; Brown ML; Fay MP; Schussler N; Potosky AL; Riley GF
J Clin Oncol; 2002 Jan; 20(1):307-16. PubMed ID: 11773184
[TBL] [Abstract][Full Text] [Related]
17. [Cost-effectiveness of trastuzumab in the treatment of early stages breast cancer patients, in Portugal].
Macedo A; Monteiro I; Andrade S; Cirrincione A; Ray J
Acta Med Port; 2010; 23(3):475-82. PubMed ID: 20654267
[TBL] [Abstract][Full Text] [Related]
18. Canada's Population Health Model (POHEM): a tool for performing economic evaluations of cancer control interventions.
Will BP; Berthelot JM; Nobrega KM; Flanagan W; Evans WK
Eur J Cancer; 2001 Sep; 37(14):1797-804. PubMed ID: 11549434
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
Pelletier EM; Shim B; Goodman S; Amonkar MM
Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
[TBL] [Abstract][Full Text] [Related]
20. Adverse breast cancer treatment effects: the economic case for making rehabilitative programs standard of care.
Schmitz KH; DiSipio T; Gordon LG; Hayes SC
Support Care Cancer; 2015 Jun; 23(6):1807-17. PubMed ID: 25471182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
